Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology.

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Biochemical Journal

• Publication date

  1979-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1042/BJ1830615PMID 261515PMCID PMC1161643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enzymes. 3rd ed

  1979cited by this paper
• Molecular basis of biological degradative processes

  1978cited by this paper
• The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes.

  1978cited by this paper
• The purification and properties of the second component of human complement.

  1978cited by this paper
• Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma.

  1977cited by this paper
• Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.

  1977cited by this paper
• Chemical characterization of human factor B of the alternate pathway of complement activation.

  1977cited by this paper
• The isolation and structure of C4, the fourth component of human complement.

  1977cited by this paper
• The unactivated form of the first component of human complement, C1.

  1976cited by this paper
• N-terminal amino acid sequences of variant-specific surface antigens from Trypanosoma brucei

  1976cited by this paper
• Isolation, by partial pepsin digestion, of the three collagen-like regions present in subcomponent Clq of the first component of human complement.

  1976cited by this paper
• The Serine Protease Nature of the C3 and C5 Convertases of the Classical and Alternative Complement Pathways

  1976cited by this paper
• Third component of human complement: purification from plasma and physicochemical characterization.

  1976cited by this paper
• The application of 0.1 M quadrol to the microsequence of proteins and the sequence of tryptic peptides.

  1975cited by this paper
• Enzymatic activity of the second component of complement.

  1975cited by this paper
• Catalysis by serine proteases and their zymogens. A study of acyl intermediates by circular dichroism.

  1975cited by this paper
• Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.

  1974cited by this paper
• FORMATION OF A HEMOLYTICALLY ACTIVE CELLULAR INTERMEDIATE BY THE INTERACTION BETWEEN PROPERDIN FACTORS B AND D AND THE ACTIVATED THIRD COMPONENT OF COMPLEMENT

  1973cited by this paper
• Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).

  1973cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• THE SECOND COMPONENT OF HUMAN COMPLEMENT: ITS ISOLATION, FRAGMENTATION BY C'1 ESTERASE, AND INCORPORATION INTO C'3 CONVERTASE

  1968cited by this paper
• FORMATION AND FUNCTIONAL SIGNIFICANCE OF A MOLECULAR COMPLEX DERIVED FROM THE SECOND AND THE FOURTH COMPONENT OF HUMAN COMPLEMENT

  1967cited by this paper

• Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy

  2023cites this paper
• A teleost complement factor Ba possesses antimicrobial activity and inhibits bacterial infection in fish

  2017cites this paper
• Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions

  2017cites this paper
• Structure-activity relationships for substrate-based inhibitors of human complement factor B.

  2009cites this paper
• Cleavage of C2 in pathological serum and plasma studied by crossed immunoelectrophoresis.

  2009cites this paper
• Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.

  2009cites this paper
• Fragment Bb in amniotic fluid: evidence for complement activation by the alternative pathway in women with intra-amniotic infection/inflammation

  2009cites this paper
• Study of alleles of the second complement component (C2) on Canadian HLA haplotypes.

  2008cites this paper
• Allotyping human complement factor B in Asian Indian type 1 diabetic patients.

  2008cites this paper
• The membrane attack complex

  2005cites this paper
• DNA polymorphism of the C2 locus

  2004cites this paper
• DNA polymorphism of the C2 and factor B genes

  2004cites this paper
• Hemolysis in PNH

  2000cites this paper
• Strategies for Inhibition of Complement Activation in the Treatment of Neurodegenerative Diseases

  1998cites this paper
• Human complement serine proteases C1r and C1s and their proenzymes.

  1993cites this paper
• Hereditary dysfunction of the third component of complement associated with a systemic lupus erythematosus-like syndrome and meningococcal meningitis.

  1992cites this paper
• Methods of Radioiodination Reactions with Several Oxidizing Agents

  1992cites this paper
• Proteolytic activity of the different fragments of factor B on the third component of complement (C3). Involvement of the N-terminal domain of Bb in magnesium binding.

  1990cites this paper
• In vitro phosphorylation of human complement factor C3 by protein kinase A and protein kinase C. Effects on the classical and alternative pathways.

  1990cites this paper
• A new, simplified method for oxidation of human complement component C2.

  1990cites this paper
• Enhanced local production of complement components in the small intestines of patients with Crohn's disease.

  1990cites this paper
• Complement and Complement Reactions

  1988cites this paper
• In vitro inhibition of the classical pathway of human complement by polymyxin B.

  1987cites this paper
• C2 Deficiency, Moderately Low lgG2 Concentrations and Lack of the G2m(23) Allotype Marker in a Child with Repeated Bacterial Infections

  1987cites this paper
• The Classical Pathway

  1986cites this paper
• Primary structure of human complement component C2. Homology to two unrelated protein families.

  1986cites this paper
• C2 and factor B: structure and genetics.

  1986cites this paper
• Inhibition of complement by a series of substituted 2-aryl-1,3-indandiones: interaction with the fifth component of complement.

  1986cites this paper
• In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.

  1986cites this paper
• Recent advances in the study of the molecular structure of the complement proteins.

  1986cites this paper
• Purification and characterization of the C3 convertase of the classical pathway of human complement system by size exclusion high-performance liquid chromatography.

  1985cites this paper
• Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.

  1985cites this paper
• Carbohydrate composition of the second, third and fifth components and factors B and D of human complement.

  1985cites this paper
• The Structure and Genetics of the C2 and Factor B Genes

  1985cites this paper
• DNA polymorphism of the C2 and factor B genes. Detection of a restriction fragment length polymorphism which subdivides haplotypes carrying the C2C and factor B F alleles.

  1985cites this paper
• The factor B and C2 genes.

  1984cites this paper
• MHC Class III products: an electron microscopic study of the C3 convertases of human complement

  1984cites this paper
• Internal homologies of the Ba fragment from human complement component Factor B, a class III MHC antigen.

  1984cites this paper
• Isolation of cDNA clones for human complement component C2.

  1984cites this paper
• The complement components of the major histocompatibility locus.

  1984cites this paper
• Complete primary structure for the zymogen of human complement factor B.

  1984cites this paper
• Structure and activation of complement components C2 and factor B.

  1984cites this paper
• Isolation and characterization of a 33,000-dalton fragment of complement Factor B with catalytic and C3b binding activity.

  1984cites this paper
• Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b‐binding protein

  1984cites this paper
• The use of monoclonal antibodies as probes of the three-dimensional structure of human complement factor D.

  1984cites this paper
• Degradation of human complement component C4b in the presence of the C4b-binding protein-protein S complex.

  1983cites this paper
• The initiation of biological function by limited proteolysis

  1983cites this paper
• Amino acid sequence of the Bb fragment from human complement Factor B. Alignment of the cyanogen bromide-cleavage peptides.

  1983cites this paper
• Determination of the second component of complement (C2) by electroimmunoassay in sera from patients with systemic lupus erythematosus.

  1983cites this paper
• beta-Endorphin and related peptides in pituitary, brain, pancreas and antrum.

  1983cites this paper
• Molecular cloning and characterization of the gene coding for human complement protein factor B.

  1983cites this paper
• Amino acid sequence of the Bb fragment from complement Factor B. Sequence of the major cyanogen bromide-cleavage peptide (CB-II) and completion of the sequence of the Bb fragment.

  1983cites this paper
• The reaction of iodine and thiol-blocking reagents with human complement components C2 and factor B. Purification and N-terminal amino acid sequence of a peptide from C2a containing a free thiol group.

  1983cites this paper
• Distribution of beta-endorphin-related peptides in rat pituitary and brain.

  1982cites this paper
• Human complement subcomponent C2: purification and proteolytic cleavage in fluid phase by C1̄s, C1̄r2–C1̄s2 AND 1̄

  1982cites this paper
• Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement.

  1982cites this paper
• Inhibition of alternative pathway factor D by factor B ‐related synthetic hexapeptides

  1982cites this paper
• Isolation, characterization and N-terminal sequences of the CNBr-cleavage peptides from human complement Factor B. Localization of a free thiol group and a sequence defining the site cleaved by factor D.

  1982cites this paper
• The human complement system serine proteases C1r and C1s and their proenzymes.

  1981cites this paper
• Human factor B.

  1981cites this paper
• The covalent-binding reaction of complement component C3.

  1981cites this paper
• Proteolysis of C2 and factor B: analyses of cleavage products by one- and two- dimensional peptide mapping.

  1981cites this paper
• The separation of functionally distinct forms of the third component of human complement (C3).

  1981cites this paper
• Human complement component C4. Structural studies on the fragments derived from C4b by cleavage with C3b inactivator.

  1981cites this paper
• Mapping the substrate binding site of human C1r and C1s with peptide thioesters. Development of new sensitive substrates.

  1981cites this paper
• The proteolytic activation systems of complement.

  1981cites this paper
• Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin.

  1981cites this paper
• The detection and characterization of a membrane protein with Factor B-like activity on human lymphoid cells.

  1981cites this paper
• Preparation of human factor D of the alternative pathway of complement.

  1981cites this paper
• The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.

  1981cites this paper
• Biosynthesis of complement by human monocytes.

  1981cites this paper
• [6] The second component of human complement

  1981cites this paper
• The human complement system: assembly of the classical pathway C3 convertase.

  1980cites this paper
• The Croonian Lecture, 1980 - The complex proteases of the complement system

  1980cites this paper
• Purification of the human complement control protein C3b inactivator.

  1980cites this paper
• Partial sequence of human complement component factor B: novel type of serine protease.

  1980cites this paper
• The binding of human complement component C4 to antibody-antigen aggregates.

  1980cites this paper
• The purification and properties of the second component of guinea-pig complement.

  1978cites this paper